Enterprise honor of Shanghai Kaibao Pharmaceutical Co., Ltd.

Tanreqing injection developed and produced by Shanghai Kaibao Pharmaceutical Co., Ltd. won the National Development and Reform Commission's "National Modern Chinese Medicine High-tech Industrialization Demonstration Project"; Shanghai key anti-SARS products; "Famous products in Shanghai pharmaceutical industry", Shanghai high-tech achievements (a) transformation project, and innovation fund support project of Ministry of Science and Technology; Shanghai Science and Technology Progress Third Prize; National Development and Reform Commission's Catalogue of Reserved Chinese Patent Medicines for Influenza Prevention and Reserved Drugs for Influenza Prevention; Shanghai brand products; Shanghai patented new products; Top 100 projects of transformation of scientific and technological achievements and top 10 projects of independent innovation in Shanghai; "Shanghai famous brand products"; It was listed as "Human Avian Influenza Diagnosis and Treatment Program" by the Ministry of Health; In 2009, it was listed by the Ministry of Health and state administration of traditional chinese medicine as "Clinical Technical Guide for Prevention and Treatment of Hand, Foot and Mouth Disease with Traditional Chinese Medicine" and "A H 1N 1 Influenza Diagnosis and Treatment Scheme (2nd Edition, Trial Edition, 2009)". Tanreqing injection has been widely recognized by doctors and patients, and has become a well-known product brand, and its market performance is in a leading position among similar products.